Full-Time

EU Regulatory Expert for Medical Devices and In-Vitro Diagnostics

Posted on 9/30/2025

ProPharma Group

ProPharma Group

1,001-5,000 employees

Regulatory sciences consultant for life sciences

No salary listed

Remote in Germany

Remote

Category
Legal & Compliance (2)
,
Required Skills
Data Analysis
Requirements
  • In depth knowledge about EU-MDR, IVDR, ISO13485, associated legislation and guidance documentation. Knowledge about legislation from other regions is preferred.
  • Experience in leading Regulatory teams and Senior Regulatory Managers.
  • Strong commercial awareness and aptitude.
  • Strong knowledge of and insight in the developments within own disciplines.
  • Strong knowledge of relevant national and international standards and guidelines in the pharmaceutical law and relevant guidelines.
  • Strong knowledge of the products and services of the organization as well as the product and service portfolios of competitors and relevant markets.
  • Strong project management skills.
  • Knowledge and understanding of all social, political, financial, economic, and technical affairs that are strategically relevant to the organisation.
  • The ability to ‘step back’ from situations and map out scenario’s and think through potential impact in advance.
  • The ability to discuss client objectives, navigate the regulatory pathway, and propose strategic solutions (where feasible) to projects in verbal and written format.
  • Strong interpersonal skills, communication, and negotiation skills.
  • Excellent attention to detail and focus on quality.
  • Strong verbal and written communication skills in.
  • Ability to prioritize workload and meet deadlines both for self and for team.
  • Capable of resolving conflict in a constructive manner.
  • Ability to collaborate with others to meet company objectives.
  • Ability to speak effectively in interpersonal situations and presentations before groups of employees and clients.
  • Flexible and proactive toward changing needs.
Responsibilities
  • Hold kick-off meetings with the clients in connection to project start (when acting as Project Manager).
  • Set up a regulatory and / or QMS strategy when needed.
  • Use the project plan (if applicable) when acting as Project Manager.
  • Ensure regular meetings with the clients are held as part of the overall project scope.
  • Ensure project stays within project scope and manages CNF / CIS accordingly (when acting as Project Manager).
  • Communicate with other service lines for cross service clients.
  • Hold business review and check-in meetings, as necessary (frequency based on revenue expectations).
  • Ensure participation in client meeting training.
  • Organize annual Group Structure review and planning with leadership.
  • Target built in agreed working capacity to take on new projects working with an agreed target capacity.
  • Monitor invoiceable performance metrics (80% target) weekly for consultants and Managing Consultants at (30%). Respond to leadership queries and investigates and discuss deviations as a normal working practice.
  • Ensure the company organogram is kept up to date by initiating a job change in the HRIS when group / structural changes occur. It is the duty of HR to update the diagram itself.
  • Act as a backup to attend the monthly EU senior management committee meeting.
  • Act as a backup to attend the monthly global committee meeting for senior management.
  • Attend regular 1-1 meetings with leadership and discusses updates on group information and utilization metrics.
  • Alert leadership when existing resource may be insufficient for existing or potential new projects.
  • Obtain leadership buy in for recruitment cycle including level of recruitment needed and timelines on at least a quarterly basis or as often as needed.
  • Monitor the Medical Device team turnover rate at 6 monthly intervals and alert the MedTech Global Head to any changes significantly above historical trending and looks for year on year reductions through a coordinated plan. Report available from HR.
  • Attend regular meetings with Business Development ahead of recruitment activities to discuss project pipeline.
  • Attend scheduled recruitment meetings with permanent and freelance recruitment.
  • Responsible for workload allocation. When allocating workload projects and activities the following is considered: Business need & the client contract, available resource within the group, staff skill sets and technical competence to undertake activities and staff development needs.
  • Keep up to date with latest regulatory guidelines and have the ability to assist members of staff on pathways forward where required.
  • Communicate any sales opportunities to Business Development.
  • Follow the business operations process for acting as a Subject Matter Expert (SME), for new contract discussion teleconferences & email queries for expert input, where relevant.
  • Understand client requirements and review contract proposals to ensure they are suitable for client’s needs.
  • Up to date knowledge of the regulatory groups pricing.
  • Have a good understanding and practical working knowledge of standard Master Service Agreements, Proposal and Work Order templates and Contracts & Timesheets Management System databases that ProPharma employs.
  • Work with Business Development and staff development plans to look at relevant conference attendance where required.
  • Input into regulatory marketing campaigns with the marketing department and ensure cohesive message with business development, where relevant.
  • Develop a strong understanding of ProPharma services, staff levels and time estimations for all regulatory affairs activities the company offers.
  • Build a strong awareness and working knowledge of ProPharma network of partners and affiliates to support clients and proposed projects.
  • Obtain a strong working knowledge of ProPharma vendor selection process and how to add persons and companies to ProPharma network.
  • Input into contract tenders and vendor qualification activities on the company’s behalf in conjunction with business development.
  • Review NDA / CDA / MSA / WO and provide SME approval for WO for business development within agreed timelines (where relevant).
  • Attend regular business development meetings.
  • Ensure the Medical Device Team are up to date with the company’s latest contract, timesheets, and invoicing training in conjunction with the quality lead (new starters within 4 weeks and annual refresh for all other staff).
  • Ensure (via the Managing Consultants, where applicable) the group as a unit does not run over time on contracts or perform out of scope activities at a loss to the company. Where possible, any risks should be known in advance of running over contract.
  • Work (with the Managing Consultants, where applicable) with finance and business development to give input and help resolve invoicing issues where they arise.
  • Follow the process with set responsibilities from contract signature to staff timesheet set-up.
  • Create / provide input, implementation, and maintenance of processes according to timelines and responsibilities listed in the Regulatory Operations group process planner.
Desired Qualifications
  • Advanced degree (e.g., MS, PhD, PharmD) is preferred.
  • Strong preference for a German speaker (preferred).
  • Knowledge about legislation from other regions is preferred.

ProPharma Group provides regulatory sciences consulting and related services for drugs, biologics, medical devices, and diagnostics on a global scale. Its offerings cover the full lifecycle, from early development and clinical trials to regulatory approval and post-market activities. The company’s services include regulatory sciences, clinical research, quality and compliance, pharmacovigilance, medical information, and R&D technology, delivered by a team of over 2,500 professionals with more than 20 years of operation. ProPharma Group differentiates itself by providing expert, end-to-end regulatory and life sciences solutions across multiple product types and stages, helping pharmaceutical, biotechnology, and medical device companies navigate complex regulatory and compliance challenges. The goal is to help clients bring safe and compliant products to market efficiently while maintaining ongoing lifecycle support.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Raleigh, North Carolina

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Hyderabad office opened November 2025 taps India's $130B pharma growth by 2030.
  • Dawn Sherman appointed CEO September 2024 drives global expansion strategy.
  • CF Box partnership revolutionizes cell/gene therapy manufacturing support.

What critics are saying

  • IQVIA undercuts prices, eroding ProPharma's pharmacovigilance share in 12-24 months.
  • Parexel acquisition intensifies clinical research competition in 6-12 months.
  • FDA AI tools automate 30% of submissions, reducing consulting demand in 18-36 months.

What makes ProPharma Group unique

  • ProPharma delivers end-to-end regulatory sciences across drugs, biologics, and devices.
  • Over 2,500 professionals provide pharmacovigilance and clinical research expertise.
  • Acquired Clinres Farmacija in 2024 to enhance CRO capabilities in Europe.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

24%
Pagal Parrot Media Private Limited
Dec 11th, 2025
ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands operations with new office in Hyderabad. Modern workspace supports continued growth and innovationRALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official inauguration of its new office in Hyderabad, India, on November 17, 2025. Strategically located in Mindspace, at the heart of Hyderabad's technology corridor (HITEC City/Madhapur), the new office places ProPharma among the world's leading Global Capability Centers (GCCs) in the pharmaceutical industry. Mindspace is also the first commercial business park in Hyderabad to receive a Gold rating from the Indian Green Building Council (IGBC). The prominent placement of the ProPharma logo atop the building underscores the company's growing presence and brand visibility in India.The expansion supports ProPharma's continued growth trajectory by providing capacity for additional team members across multiple service lines and creating a modern, collaborative environment designed to inspire innovation and connection. More than 70 employees participated in the inaugural celebration."This milestone represents an important step forward in ProPharma's global expansion," said Jason DeGoes, President, ProPharma. "Our new Hyderabad office strengthens our ability to deliver high-quality, integrated solutions for our clients around the world and reflects our commitment to building an exceptional environment for our teams.""We're proud to establish a world-class workspace in Hyderabad - one designed to foster creativity, efficiency, and collaboration," added Pavan Hemadri, Director of Business Operations, ProPharma. "This move enhances our ability to attract top local talent and better serve our clients across regulatory, clinical, and compliance domains."The new state-of-the-art facility features open, collaborative workspaces aligned with ProPharma's global culture of innovation and operational excellence. It also underscores ProPharma's long-term investment in India as a key hub supporting its worldwide operations.About ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, FSP solutions, and digital transformation, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate its partners' most high-profile drug and device programs. For more information about ProPharma, please visit propharmagroup.com.About Odyssey Investment PartnersOdyssey Investment Partners is a leading private equity investment firm with more than a 25-year history of partnering with skilled managers to transform middle-market companies into more efficient and diversified businesses with strong growth profiles. Odyssey makes majority-controlled investments in industries with a long-term positive outlook and favorable secular trends. For further information about Odyssey, please visit odysseyinvestment.com.Logo - https://www.pagalparrot.com/wp-content/uploads/2025/12/ProPharma_Group_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/propharma-expands-operations-with-new-office-in-hyderabad-302638474.html

CNHI
Oct 21st, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer

RALEIGH, N.C., Oct. 21, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that Brian Tuttle has been named Chief Financial Officer.

Kilgore News Herald
Oct 9th, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

RALEIGH, N.C., Oct. 9, 2024 /PRNewswire/ - ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, is pleased to announce it has won the prestigious CPHI Pharma Award for Regulatory and Compliance.

PR Newswire
Sep 30th, 2024
ProPharma Names Dawn Sherman Chief Executive Officer

RALEIGH, N.C., Sept. 30, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced that Dawn Sherman has been appointed Chief Executive Officer.

GlobalData
Sep 24th, 2024
Clinical Trials Arena Excellence Awards 2024: ProPharma

ProPharma, a global research consulting company headquartered in the US, has won two awards in the 2024 Clinical Trials Arena Excellence Awards, in the Business Expansion and M&A categories, celebrating its acquisition of the Croatia-based contract research organization (CRO), Clinres Farmacija.

INACTIVE